查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1825910

2025年全球檢體功效測試市場報告

Specimen Validity Testing Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年檢體有效性檢測市場規模將強勁成長，到2029年將達到55.9億美元，複合年成長率為8.6%。預測期內的成長歸因於職場藥物檢測需求的不斷成長、口腔液體檢測的日益普及、研發活動的不斷增加、SVT的使用率的不斷提高以及在疼痛管理領域的應用不斷拓展。預測期內的主要趨勢包括技術進步、人工智慧在結果解讀中的應用、產品創新、夥伴關係關係的不斷加強以及用於行動監測的攜帶式檢測設備的開發。

未來五年8.6%的成長預測，較我們先前對該市場的預測略有下降0.8%。這一下降主要源自於美國與其他國家之間關稅的影響。徵收關稅可能會擾亂美國實驗室的營運，因為這會增加從巴西和波蘭進口的摻假試紙和自動檢體可用性分析儀的成本，從而降低藥物檢測的準確性並增加毒理學實驗室的成本。由於互惠關稅以及貿易緊張局勢和限制措施升級對美國經濟和貿易的負面影響，關稅的影響可能更為廣泛。

日益嚴重的藥物濫用問題預計將推動檢體有效性測試 (SVT) 市場的成長。藥物濫用是指將合法或非法物質頻繁、過量或不當用於非醫療目的。藥物濫用的增加歸因於幾個相互關聯的因素，包括鴉片類藥物氾濫、日益嚴重的精神健康問題、獲得治療和支持資源的管道有限，以及流行文化中對吸毒的刻畫。 SVT 方法旨在透過分析各種參數（例如 pH 值、比重、肌酸酐水平和溫度）來檢測雜質或物質的存在。例如，2023年10月，英國政府機構健康改善與差異辦公室報告稱，2021年4月至2022年3月期間，成年人參與藥物和酒精計畫的次數從上一年的28萬次增加到29萬次。此外，2024年10月，英國政府機構國家統計局透露，2023年英格蘭和威爾斯因藥物中毒死亡的人數將達到5,448人，比2022年的4907人增加11.0%。因此，預計藥物濫用的增加將促進檢體有效性測試市場的成長。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球檢體有效性測試：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球檢體有效性測試市場：成長率分析
  • 全球檢體驗證測試市場表現：規模與成長，2019-2024
  • 全球檢體驗證測試市場預測：規模與成長，2024-2029 年，2034 年
  • 全球檢體功效測試：總目標市場（TAM）

第6章 市場細分

  • 全球檢體有效性測試市場：依產品及服務分類，實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 產品
  • 服務
  • 全球檢體驗證測試市場：按測試類型、效能和預測，2019-2024 年、2024-2029 年、2034 年
  • 實驗室檢查
  • 快速或就地檢驗
  • 全球檢體驗證測試市場：按最終用戶、實際和預測，2019-2024 年、2024-2029 年、2034 年
  • 戒毒中心
  • 藥物篩檢實驗室
  • 疼痛管理中心
  • 刑事司法和執法
  • 其他最終用戶
  • 全球檢體驗證測試市場：按產品（類型）、性能和預測細分，2019-2024 年、2024-2029 年、2034 年
  • 試劑和檢測試劑套件
  • 控制設備和校準器
  • 檢體裝置
  • 分析設備和儀器
  • 全球檢體有效性測試市場：按服務類型、績效和預測細分，2019-2024 年、2024-2029 年、2034 年
  • 實驗室測試服務
  • 就地檢驗服務

第7章 區域和國家分析

  • 全球檢體驗證測試市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球檢體驗證測試市場：依國家、表現及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章：俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 檢體有效性測試市場：競爭格局
  • 檢體有效性測試市場：公司簡介
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis
    • Medline Industries Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Becton, Dickinson and Company
  • Laboratory Corporation
  • Quest Diagnostics Incorporated
  • Alere Inc.
  • Clinical Reference Laboratory Inc.
  • Precision Diagnostics
  • ACM Global Laboratories
  • Millennium Health
  • Omega Laboratories Inc.
  • Dominion Diagnostics
  • CannAmm
  • Sciteck Inc.
  • Starplex Scientific Inc.
  • Vision Diagnostics Inc.
  • Premier Biotech Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029年檢體有效性測試市場：提供新機會的國家
  • 2029年檢體有效性測試市場：細分市場帶來新機會
  • 2029年檢體功效測試市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r31284u

Specimen Validity Testing (SVT) is a crucial process utilized to evaluate the integrity and authenticity of biological specimens, including urine, blood, saliva, or hair samples, collected for drug testing or clinical analysis. SVT scrutinizes diverse parameters such as pH, creatinine levels, specific gravity, and the presence of common masking agents such as oxidizing adulterants, nitrites, glutaraldehyde, and pyridinium chlorochromate.

Within the specimen validity testing market, products and services are the main offerings. Products encompass assay kits, reagents, calibrators, and disposables employed in the testing procedure to identify any adulteration, dilution, or substitution in urine samples. Various testing types include laboratory testing and rapid or point-of-care testing, catering to a range of end-users such as drug rehabilitation centers, drug screening laboratories, pain management centers, criminal justice and law enforcement agencies, among others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The specimen validity testing market research report is one of a series of new reports from The Business Research Company that provides specimen validity testing market statistics, including the specimen validity testing industry global market size, regional shares, competitors with a specimen validity testing market share, detailed specimen validity testing market segments, market trends, and opportunities, and any further data you may need to thrive in the specimen validity testing industry. This specimen validity testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The specimen validity testing market size has grown strongly in recent years. It will grow from $3.68 billion in 2024 to $4.03 billion in 2025 at a compound annual growth rate (CAGR) of 9.5%. The growth in the historic period can be attributed to increasing drug adoption, increased drug screening, stringent regulations, increased alcohol use, and integration of point-of-care testing.

The specimen validity testing market size is expected to see strong growth in the next few years. It will grow to $5.59 billion in 2029 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to rising demand for workplace drug testing, growing adoption of oral fluid testing, rise in research and development operations, rising usage of SVTand expanding applications in pain management. Major trends in the forecast period include technological advancements, integration of artificial intelligence for result interpretation, product innovations, increasing partnerships, and the development of portable testing devices for on-the-go monitoring.

The forecast of 8.6% growth over the next five years reflects a modest reduction of 0.8% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may disrupt U.S. lab operations by increasing costs for adulteration test strips and automated specimen validity analyzers imported from Brazil and Poland, risking compromised drug testing accuracy and higher toxicology lab expenses. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growing issue of drug abuse is anticipated to drive the expansion of the specimen validity testing (SVT) market. Drug abuse refers to the frequent, excessive, or inappropriate use of legal or illegal substances for non-medical purposes. The rise in drug abuse can be attributed to multiple interrelated factors, including the opioid epidemic, increasing mental health challenges, limited access to treatment and support resources, and portrayals of drug use in popular culture. SVT methods are designed to detect the presence of impurities and substances by analyzing various parameters such as pH, specific gravity, creatinine levels, and temperature. For example, in October 2023, the Office for Health Improvement and Disparities, a UK government agency, reported an increase in adult interactions with drug and alcohol programs, from 0.28 million in the previous year to 0.29 million between April 2021 and March 2022. Furthermore, in October 2024, the Office for National Statistics, a UK government body, revealed that drug poisoning-related deaths in England and Wales reached 5,448 in 2023, marking an 11.0% increase from the 4,907 deaths recorded in 2022. As a result, the rising incidence of drug abuse is expected to contribute to the growth of the specimen validity testing market.

Key players in the specimen validity testing market are focused on developing innovative products such as high-resolution urine drug testing profiles to maintain their market position. A high-resolution urine drug testing profile employs advanced analytical techniques for sophisticated testing. For instance, in July 2022, Mayo Clinic Laboratories introduced a data-driven urine drug testing (UDT) profile aimed at providing physicians with comprehensive information to manage patients addicted to common substances such as prescription opioids, alcohol, marijuana, and nicotine. This addiction medicine monitoring profile (Mayo ID ADMPU) complies with the American Society of Addiction Medicine's guidelines and offers enhanced sensitivity and specificity to detect parent drugs and metabolites from various drug classes, including opioids, benzodiazepines, stimulants, and PCP. Utilizing high-resolution, accurate mass spectrometry and targeted immunoassay testing, the profile delivers clinically relevant information for healthcare providers.

In November 2024, SPT Labtech, a UK-based company specializing in the design and manufacturing of automated laboratory instruments, formed a partnership with ICE Bioscience. This collaboration aims to advance drug discovery by leveraging state-of-the-art drug screening and automation technologies. By improving assay development and expanding research capabilities, the partnership seeks to drive innovation in the pharmaceutical industry. ICE Bioscience, based in China, is a provider of drug screening platforms.

Major companies operating in the specimen validity testing market are Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers, Medline Industries Inc., Becton, Dickinson and Company, Laboratory Corporation, Quest Diagnostics Incorporated, Alere Inc., Clinical Reference Laboratory Inc., Precision Diagnostics, ACM Global Laboratories, Millennium Health, Omega Laboratories Inc., Dominion Diagnostics, CannAmm, Sciteck Inc., Starplex Scientific Inc., Vision Diagnostics Inc., Premier Biotech Inc., Alfa Scientific Designs, Express Diagnostics, American Bio Medica Corporation, Titan Biotech Ltd., SureHire, Miraclean Technology Co. Ltd.

North America was the largest region in the specimen validity testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the specimen validity testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the specimen validity testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The specimen validity testing market includes revenues earned by entities by creatinine testing, pH testing, adulterant testing, and specific gravity measurement and related specimen collection containers, urine test strips, adulterant detection kits, and temperature strips. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Specimen Validity Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on specimen validity testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for specimen validity testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The specimen validity testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product And Service: Products; Service
  • 2) By Testing Type: Laboratory Testing; Rapid Or Point-Of-Care Testing
  • 3) By End-User: Drug Rehabilitation Centers; Drug Screening Laboratories; Pain Management Centers; Criminal Justice And Law Enforcement Agencies; Other End-Users
  • Subsegments:
  • 1) By Products: Reagents And Assay Kits; Controls And Calibrators; Specimen Collection Devices; Analyzers And Instruments
  • 2) By Service: Laboratory Testing Services; Point-Of-Care Testing Services
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Siemens Healthineers ; Medline Industries Inc.; Becton, Dickinson and Company; Laboratory Corporation; Quest Diagnostics Incorporated; Alere Inc.; Clinical Reference Laboratory Inc.; Precision Diagnostics; ACM Global Laboratories; Millennium Health; Omega Laboratories Inc.; Dominion Diagnostics; CannAmm; Sciteck Inc.; Starplex Scientific Inc.; Vision Diagnostics Inc.; Premier Biotech Inc.; Alfa Scientific Designs; Express Diagnostics; American Bio Medica Corporation; Titan Biotech Ltd.; SureHire; Miraclean Technology Co. Ltd
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Specimen Validity Testing Market Characteristics

3. Specimen Validity Testing Market Trends And Strategies

4. Specimen Validity Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Specimen Validity Testing Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Specimen Validity Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Specimen Validity Testing Market Growth Rate Analysis
  • 5.4. Global Specimen Validity Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Specimen Validity Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Specimen Validity Testing Total Addressable Market (TAM)

6. Specimen Validity Testing Market Segmentation

  • 6.1. Global Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Products
  • Service
  • 6.2. Global Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Laboratory Testing
  • Rapid Or Point-Of-Care Testing
  • 6.3. Global Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Drug Rehabilitation Centers
  • Drug Screening Laboratories
  • Pain Management Centers
  • Criminal Justice And Law Enforcement Agencies
  • Other End-Users
  • 6.4. Global Specimen Validity Testing Market, Sub-Segmentation Of Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Reagents And Assay Kits
  • Controls And Calibrators
  • Specimen Collection Devices
  • Analyzers And Instruments
  • 6.5. Global Specimen Validity Testing Market, Sub-Segmentation Of Service, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Laboratory Testing Services
  • Point-Of-Care Testing Services

7. Specimen Validity Testing Market Regional And Country Analysis

  • 7.1. Global Specimen Validity Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Specimen Validity Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Specimen Validity Testing Market

  • 8.1. Asia-Pacific Specimen Validity Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Specimen Validity Testing Market

  • 9.1. China Specimen Validity Testing Market Overview
  • 9.2. China Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Specimen Validity Testing Market

  • 10.1. India Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Specimen Validity Testing Market

  • 11.1. Japan Specimen Validity Testing Market Overview
  • 11.2. Japan Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Specimen Validity Testing Market

  • 12.1. Australia Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Specimen Validity Testing Market

  • 13.1. Indonesia Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Specimen Validity Testing Market

  • 14.1. South Korea Specimen Validity Testing Market Overview
  • 14.2. South Korea Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Specimen Validity Testing Market

  • 15.1. Western Europe Specimen Validity Testing Market Overview
  • 15.2. Western Europe Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Specimen Validity Testing Market

  • 16.1. UK Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Specimen Validity Testing Market

  • 17.1. Germany Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Specimen Validity Testing Market

  • 18.1. France Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Specimen Validity Testing Market

  • 19.1. Italy Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Specimen Validity Testing Market

  • 20.1. Spain Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Specimen Validity Testing Market

  • 21.1. Eastern Europe Specimen Validity Testing Market Overview
  • 21.2. Eastern Europe Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Specimen Validity Testing Market

  • 22.1. Russia Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Specimen Validity Testing Market

  • 23.1. North America Specimen Validity Testing Market Overview
  • 23.2. North America Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Specimen Validity Testing Market

  • 24.1. USA Specimen Validity Testing Market Overview
  • 24.2. USA Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Specimen Validity Testing Market

  • 25.1. Canada Specimen Validity Testing Market Overview
  • 25.2. Canada Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Specimen Validity Testing Market

  • 26.1. South America Specimen Validity Testing Market Overview
  • 26.2. South America Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Specimen Validity Testing Market

  • 27.1. Brazil Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Specimen Validity Testing Market

  • 28.1. Middle East Specimen Validity Testing Market Overview
  • 28.2. Middle East Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Specimen Validity Testing Market

  • 29.1. Africa Specimen Validity Testing Market Overview
  • 29.2. Africa Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Specimen Validity Testing Market Competitive Landscape And Company Profiles

  • 30.1. Specimen Validity Testing Market Competitive Landscape
  • 30.2. Specimen Validity Testing Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Medline Industries Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Specimen Validity Testing Market Other Major And Innovative Companies

  • 31.1. Becton, Dickinson and Company
  • 31.2. Laboratory Corporation
  • 31.3. Quest Diagnostics Incorporated
  • 31.4. Alere Inc.
  • 31.5. Clinical Reference Laboratory Inc.
  • 31.6. Precision Diagnostics
  • 31.7. ACM Global Laboratories
  • 31.8. Millennium Health
  • 31.9. Omega Laboratories Inc.
  • 31.10. Dominion Diagnostics
  • 31.11. CannAmm
  • 31.12. Sciteck Inc.
  • 31.13. Starplex Scientific Inc.
  • 31.14. Vision Diagnostics Inc.
  • 31.15. Premier Biotech Inc.

32. Global Specimen Validity Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Specimen Validity Testing Market

34. Recent Developments In The Specimen Validity Testing Market

35. Specimen Validity Testing Market High Potential Countries, Segments and Strategies

  • 35.1 Specimen Validity Testing Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Specimen Validity Testing Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Specimen Validity Testing Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer